Onelar (Duloxetine)

Duloxetine, the active ingredient in Onelar, is a serotonin‑norepinephrine reuptake inhibitor (SNRI) presented as a unknown/unknown for oral use. It treats major depressive disorder and generalized anxiety disorder in adults. GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Onelar as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Onelar is an SNRI that modulates neurotransmitter activity in several mood‑related conditions.

- Major depressive disorder: alleviates depressive symptoms and improves functional outcomes. - Generalized anxiety disorder: reduces anxiety symptoms and associated physiological arousal. - Diabetic peripheral neuropathic pain: provides analgesic relief in chronic nerve pain. - Fibromyalgia: lessens widespread musculoskeletal pain and fatigue. - Chronic musculoskeletal ​  ​  ​ ​  ​  ​ ​  ​  ​  ​  ​  ​

Common       ​  ​  ...  ....  …  ...  ... ‑  … … … … …